Ono Pharmaceutical Co., Ltd. (4528.T)
JPY 1682.5
(3.67%)
JPY 1682.5
(3.67%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 913.66 Billion JPY | 3.54% |
| 2022 | 882.43 Billion JPY | 19.38% |
| 2021 | 739.2 Billion JPY | -1.02% |
| 2020 | 746.84 Billion JPY | 10.9% |
| 2019 | 673.44 Billion JPY | 2.81% |
| 2018 | 655.05 Billion JPY | 7.52% |
| 2017 | 609.22 Billion JPY | -1.33% |
| 2016 | 617.46 Billion JPY | 14.25% |
| 2015 | 540.45 Billion JPY | 3.02% |
| 2014 | 524.58 Billion JPY | 7.95% |
| 2013 | 485.96 Billion JPY | 6.67% |
| 2012 | 455.57 Billion JPY | 4.39% |
| 2011 | 436.41 Billion JPY | 2.82% |
| 2010 | 424.44 Billion JPY | -2.03% |
| 2009 | 433.22 Billion JPY | 2.84% |
| 2008 | 421.28 Billion JPY | -11.74% |
| 2007 | 477.34 Billion JPY | -5.44% |
| 2006 | 504.81 Billion JPY | 0.07% |
| 2005 | 504.44 Billion JPY | 14.84% |
| 2004 | 439.27 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1046.4 Billion JPY | -3.44% |
| 2024 Q1 | 1083.69 Billion JPY | 18.61% |
| 2023 Q2 | 895.91 Billion JPY | 2.76% |
| 2023 Q1 | 871.87 Billion JPY | -1.2% |
| 2023 Q3 | 891.72 Billion JPY | -0.47% |
| 2023 FY | 913.66 Billion JPY | 3.54% |
| 2023 Q4 | 913.66 Billion JPY | 2.46% |
| 2022 Q3 | 830.53 Billion JPY | 3.17% |
| 2022 FY | 882.43 Billion JPY | 19.38% |
| 2022 Q4 | 882.43 Billion JPY | 6.25% |
| 2022 Q2 | 805 Billion JPY | 5.34% |
| 2022 Q1 | 764.18 Billion JPY | 3.38% |
| 2021 FY | 739.2 Billion JPY | -1.02% |
| 2021 Q3 | 740.05 Billion JPY | -4.25% |
| 2021 Q4 | 739.2 Billion JPY | -0.12% |
| 2021 Q2 | 772.9 Billion JPY | 4.04% |
| 2021 Q1 | 742.87 Billion JPY | -0.53% |
| 2020 FY | 746.84 Billion JPY | 10.9% |
| 2020 Q4 | 746.84 Billion JPY | 3.87% |
| 2020 Q2 | 706.79 Billion JPY | 4.17% |
| 2020 Q1 | 678.5 Billion JPY | 0.75% |
| 2020 Q3 | 718.99 Billion JPY | 1.73% |
| 2019 Q2 | 642.12 Billion JPY | 0.17% |
| 2019 Q3 | 659.21 Billion JPY | 2.66% |
| 2019 Q1 | 641.06 Billion JPY | -2.14% |
| 2019 Q4 | 673.44 Billion JPY | 2.16% |
| 2019 FY | 673.44 Billion JPY | 2.81% |
| 2018 Q2 | 640.19 Billion JPY | 3.48% |
| 2018 Q3 | 629.39 Billion JPY | -1.69% |
| 2018 FY | 655.05 Billion JPY | 7.52% |
| 2018 Q1 | 618.65 Billion JPY | 1.55% |
| 2018 Q4 | 655.05 Billion JPY | 4.08% |
| 2017 FY | 609.22 Billion JPY | -1.33% |
| 2017 Q4 | 609.22 Billion JPY | 2.18% |
| 2017 Q3 | 596.2 Billion JPY | 3.4% |
| 2017 Q2 | 576.59 Billion JPY | -0.13% |
| 2017 Q1 | 577.33 Billion JPY | -6.5% |
| 2016 Q3 | 583.4 Billion JPY | 4.6% |
| 2016 Q1 | 540.4 Billion JPY | -0.01% |
| 2016 Q2 | 557.75 Billion JPY | 3.21% |
| 2016 Q4 | 617.46 Billion JPY | 5.84% |
| 2016 FY | 617.46 Billion JPY | 14.25% |
| 2015 FY | 540.45 Billion JPY | 3.02% |
| 2015 Q4 | 540.45 Billion JPY | 1.71% |
| 2015 Q3 | 531.36 Billion JPY | 2.85% |
| 2015 Q2 | 516.63 Billion JPY | -2.12% |
| 2015 Q1 | 527.83 Billion JPY | 0.62% |
| 2014 Q1 | 489.2 Billion JPY | 0.67% |
| 2014 FY | 524.58 Billion JPY | 7.95% |
| 2014 Q4 | 524.58 Billion JPY | 3.75% |
| 2014 Q3 | 505.63 Billion JPY | 3.7% |
| 2014 Q2 | 487.57 Billion JPY | -0.33% |
| 2013 Q4 | 485.96 Billion JPY | 2.57% |
| 2013 FY | 485.96 Billion JPY | 6.67% |
| 2013 Q2 | 460.8 Billion JPY | 1.37% |
| 2013 Q3 | 473.79 Billion JPY | 2.82% |
| 2013 Q1 | 454.57 Billion JPY | -0.22% |
| 2012 Q4 | 455.57 Billion JPY | 5.04% |
| 2012 Q2 | 430.03 Billion JPY | -0.49% |
| 2012 Q1 | 432.16 Billion JPY | -0.97% |
| 2012 FY | 455.57 Billion JPY | 4.39% |
| 2012 Q3 | 433.72 Billion JPY | 0.86% |
| 2011 FY | 436.41 Billion JPY | 2.82% |
| 2011 Q3 | 421.71 Billion JPY | -0.67% |
| 2011 Q2 | 424.55 Billion JPY | 0.22% |
| 2011 Q1 | 423.62 Billion JPY | -0.19% |
| 2011 Q4 | 436.41 Billion JPY | 3.48% |
| 2010 FY | 424.44 Billion JPY | -2.03% |
| 2010 Q2 | 423.03 Billion JPY | -0.99% |
| 2010 Q3 | 426.09 Billion JPY | 0.72% |
| 2010 Q4 | 424.44 Billion JPY | -0.39% |
| 2010 Q1 | 427.28 Billion JPY | -1.37% |
| 2009 FY | 433.22 Billion JPY | 2.84% |
| 2009 Q4 | 433.22 Billion JPY | 1.2% |
| 2009 Q3 | 428.07 Billion JPY | -1.77% |
| 2009 Q2 | 435.78 Billion JPY | 0.0% |
| 2008 Q3 | 428.44 Billion JPY | 0.0% |
| 2008 FY | 421.28 Billion JPY | -11.74% |
| 2008 Q4 | 421.28 Billion JPY | -1.67% |
| 2007 FY | 477.34 Billion JPY | -5.44% |
| 2006 FY | 504.81 Billion JPY | 0.07% |
| 2005 FY | 504.44 Billion JPY | 14.84% |
| 2004 FY | 439.27 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 1025.94 Billion JPY | 10.944% |
| Astellas Pharma Inc. | 3569.6 Billion JPY | 74.404% |
| Chugai Pharmaceutical Co., Ltd. | 1932.54 Billion JPY | 52.722% |
| Santen Pharmaceutical Co., Ltd. | 435.69 Billion JPY | -109.702% |
| JCR Pharmaceuticals Co., Ltd. | 102.22 Billion JPY | -793.773% |
| Daiichi Sankyo Company, Limited | 3461.13 Billion JPY | 73.602% |
| Otsuka Holdings Co., Ltd. | 3361.24 Billion JPY | 72.818% |
| Perseus Proteomics Inc. | 1.69 Billion JPY | -53841.587% |